stockrowCVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- +154.1%
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) Revenue growth
CVS Health Corporation's revenue growth over the twelve months to 30 September 2026 was 6.73%, down 1.1 percentage points from fiscal 2025 (7.85%). Over the past ten years it has ranged from 4.08% (fiscal 2017) to 32.0% (fiscal 2019); the current reading is higher than 45% of that period. That is in line with the Healthcare Plans industry median of 6.77% and below the Healthcare sector median of 7.98%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 7.85% | 3.65 |
| FY2024 | 4.20% | (6.75) |
| FY2023 | 11.0% | 0.56 |
| FY2022 | 10.4% | 1.68 |
| FY2021 | 8.71% | 4.06 |
| FY2020 | 4.65% | (27.31) |
| FY2019 | 32.0% | 26.66 |
| FY2018 | 5.30% | 1.22 |
| FY2017 | 4.08% | (11.74) |
| FY2016 | 15.8% | 5.83 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 5.37% | (1.89) |
| Jun 2026 | 7.26% | 1.09 |
| Mar 2026 | 6.17% | (2.00) |
| Dec 2025 | 8.17% | 0.37 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| OSCR Oscar Health, Inc. compare | 54.8% |
| HUM Humana Inc. compare | 22.0% |
| CNC Centene Corporation compare | 9.71% |
| CI Cigna Group compare | 6.80% |
| CVS CVS Health Corporation | 6.73% |
| PGNY Progyny, Inc. compare | 5.52% |
| ELV Elevance Health, Inc. compare | 3.60% |
| UNH UnitedHealth Group Incorporated compare | 3.33% |
| MOH Molina Healthcare, Inc compare | −0.95% |
| Healthcare Plans industry median | 6.77% |
| Healthcare sector median | 7.98% |
| Market median | 7.71% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement